[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | Sponsor | E-mail ]

Turkish Journal of Cancer
2009, Volume 39, Number 4, Page(s) 138-147
[ Summary ] [ Full Text ] [ PDF ]
The clinical relevance of the correlation of NM 23-H1 expression with PAP, PSA and Androgen Receptors in patients with Prostate Cancer and BPH
MEHMET BUDAK1, DİCLEHAN ORHAN2, ÖZDEN TULUNAY3, ORHAN GÖĞÜŞ4
1Gazi University, Nanomedicine and Advanced Technologies Research Center, Ankara-Turkey
2Hacettepe University, Department of Pathology, Ankara-Turkey
3Ankara University, Departments of Pathology, Ankara-Turkey
4Ankara University, Departments of Urology, Ankara-Turkey

We investigate the correlation of the tissue expressions of NM23-H1, androgen receptor, serum PSA and PAP in patients with prostate cancer and benign prostatic hyperplasia to search for the possible relevance for the prognosis. Seventy-five patients were included to study, of these, 55 were diagnosed with prostate cancer and 20 with benign prostatic hyperplasia. Twenty-eight percent of stage I, 54% of stage II, 33 % of stage III and IV cases show the NM23- H1 expressions. The metastatic and nodal diseases (55%) mostly showed the strong intensity of NM23-H1. The correlations between stages and NM23-H1 expression were not statistically significant. A variable but steady NM23 staining from all different stages was noted. However, no correlations among NM23-H1, AR, PSA, PAP and tumor grading in terms of disease prognosis were seen, except for the moderately differentiated tumors with moderate PSA expression levels which have the statistically significant correlation with increased expression of the NM23-H1. [Turk J Cancer 2009;39(4):136-145]

[ Summary ] [ Full Text ] [ PDF ]
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | E-mail ]